Detalhe da pesquisa
1.
Interobserver agreement of current and new proposed endoscopic scores for postoperative recurrence in Crohn's disease.
Gastrointest Endosc
; 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38462057
2.
Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn's Disease.
Clin Gastroenterol Hepatol
; 21(11): 2918-2927.e6, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37004971
3.
Significant Differences in IBD Care and Education across Europe: Results of the Pan-European VIPER Survey.
Dig Dis
; 41(3): 387-395, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36412565
4.
Quality of Surveillance Impacts the Colitis-Associated Advanced Neoplasia Risk: A Multicenter Case-Control Study.
Clin Gastroenterol Hepatol
; 2022 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572110
5.
Increased Colorectal Neoplasia Risk in Patients with Inflammatory Bowel Disease and Serrated Polyps with Dysplasia.
Dig Dis Sci
; 67(12): 5647-5656, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35380348
6.
Increased risk of high-grade dysplasia and colorectal cancer in inflammatory bowel disease patients with recurrent low-grade dysplasia.
Gastrointest Endosc
; 91(6): 1334-1342.e1, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31923409
7.
Colorectal Cancer Risk in Patients With Lynch Syndrome and Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 15(3): 454-458.e1, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27521512
8.
Long-Term Clinical Outcomes After Switching from Remicade® to Biosimilar CT-P13 in Inflammatory Bowel Disease.
Dig Dis Sci
; 62(11): 3117-3122, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28667429
9.
Is the prevalence of colonic neuroendocrine tumors increased in patients with inflammatory bowel disease?
Int J Cancer
; 139(3): 535-42, 2016 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26992110
10.
Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol
; 14(6): 798-806.e20, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26407752
11.
Endoscopy in patients with diarrhea during treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors: Is the cause in the mucosa?
Acta Oncol
; 55(4): 444-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26959411
12.
Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
Gastroenterology
; 146(1): 119-28.e1, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24076060
13.
Management of colorectal neoplasia in IBD patients: current practice and future perspectives.
J Crohns Colitis
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38741227
14.
Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis.
Inflamm Bowel Dis
; 29(10): 1633-1647, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36318229
15.
SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis.
Therap Adv Gastroenterol
; 16: 17562848231174295, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461739
16.
Rates, predictive factors and effectiveness of ustekinumab intensification to 4- or 6-weekly intervals in Crohn's disease.
Dig Liver Dis
; 55(8): 1034-1041, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36283944
17.
Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort.
United European Gastroenterol J
; 11(2): 179-188, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802176
18.
Endoscopic and surgical treatment outcomes of colitis-associated advanced colorectal neoplasia: a multicenter cohort study.
Int J Surg
; 109(7): 1961-1969, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300890
19.
Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland: a retrospective prevalent cohort analysis.
Aliment Pharmacol Ther
; 56(1): 67-76, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35301734
20.
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients.
J Crohns Colitis
; 16(3): 389-397, 2022 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34473254